共 7 条
[1]
Fahey J., Taylor J., Detels R., Et al., The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type-1, N Engl J Med, 322, pp. 166-172, (1990)
[2]
Giorgi J., Detels R., T-cell subset alterations in HIV-1 infected homosexual men: NIAID Multicenter AIDS Cohort Study, Clin Immunol Immuno-Pathol, 52, pp. 10-18, (1989)
[3]
Phair I.B., Jacobson L., Detels R., Et al., Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The Multicenter AIDS Cohort Study, J Acquir Immune Defic Syndr, 5, pp. 490-496, (1992)
[4]
Sande M.A., Carpenter C.O., Cobbs C.A., Et al., Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference, JAMA, 270, pp. 2583-2589, (1993)
[5]
Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons with human immunodeficiency vims, J Acquir Immune Defic Syndr, 6, pp. 46-55, (1993)
[6]
Nightingale S.D., Cameron D., Garden F., Et al., Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS, N Engl J Med, 329, pp. 828-833, (1993)
[7]
Carr A., Tindall B., Brew B.J., Et al., Lose-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS, Ann Intern Med, 117, pp. 106-111, (1992)